These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Epoetin alfa as an adjunct to autologous blood donation in patients with a low hematocrit scheduled for elective orthopedic surgery. Adamson J. Semin Hematol; 1996 Apr; 33(2 Suppl 2):15-6; discussion 17. PubMed ID: 8723575 [Abstract] [Full Text] [Related]
17. Comparison between intravenous and subcutaneous recombinant human erythropoietin (Epoetin alfa) administration in presurgical autologous blood donation in anemic rheumatoid arthritis patients undergoing major orthopedic surgery. Mercuriali F, Inghilleri G, Biffi E, Colotti MT, Vinci A, Sinigaglia L, Gualtieri G. Vox Sang; 1997 Apr; 72(2):93-100. PubMed ID: 9088076 [Abstract] [Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial. Vincent JL, Spapen HD, Creteur J, Piagnerelli M, Hubloue I, Diltoer M, Roman A, Stevens E, Vercammen E, Beaver JS. Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233 [Abstract] [Full Text] [Related]
19. A comparison between once-weekly and twice- or thrice-weekly subcutaneous injection of epoetin alfa: results from a randomized controlled multicentre study. Lee YK, Kim SG, Seo JW, Oh JE, Yoon JW, Koo JR, Kim HJ, Noh JW. Nephrol Dial Transplant; 2008 Oct; 23(10):3240-6. PubMed ID: 18469158 [Abstract] [Full Text] [Related]